Reduction of ultraviolet‐induced skin cancer in mice by topical application of DNA excision repair enzymes

$48.00 plus tax (Refund Policy)

Download / Buy Article:


Ultraviolet (UV) irradiation produces two major photoproducts, cyclobutane pyrimidine dimers (CPD) and (6–4) photoproducts. T4 endonuclease V (T4N5), which specifically repairs CPD, is encapsulated in liposomes. A previous study has shown that UV‐induced carcinogenesis in mice was suppressed by the application of T4N5 liposomes. To confirm the suppressive effect, we applied T4N5 liposomes with repeated UVB exposure to hairless mice. At the end of the experiment, mice treated with T4N5 liposomes had 3.5 ± 1.3 tumors per mouse, and control mice had 6.3 ± 2.8 tumors per mouse. In addition, the incidence of tumors was reduced in T4N5 liposome‐treated mice compared with controls. The pathological diagnosis of the tumors was not significantly different between two groups. Immunohistochemical analysis of p53 protein in UV‐induced tumors showed that nearly half of the tumors in both groups were positive. When the biopsied normal‐looking skin taken during the experiment was stained with p53 antibody, there was no significant difference of the timing of p53 protein expression between the control mice and T4N5 liposome‐treated mice. These results confirmed that CPD plays a pivotal role in UV carcinogenesis, although the molecular mechanisms of the suppression by T4N5 liposomes should be further clarified.

Document Type: Original Article


Affiliations: 1: Department of Dermatology, Kobe University School of Medicine 2: Department of Medicinal Chemistry, Meiji College of Pharmacy, Japan

Publication date: February 1, 1995

Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more